FindTrial
Sign In

BinD19

BIOLOGICAL2 trials

Sponsors

Shenzhen BinDeBio Ltd.

Conditions

Refractory B-cell Acute Lymphoblastic LeukemiaRefractory B-cell Acute Lymphoblastic Leukemia, ChildhoodRelapsed B-cell Acute Lymphoblastic LeukemiaRelapsed B-cell Acute Lymphoblastic Leukemia, ChildhoodRelapsed/Refractory B-cell Lymphoma, ChildhoodRelapsed／Refractory B-cell Lymphoma

Phase 1

A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in R/R ALL and Lymphoma Subjects
NCT03156101
Shenzhen BinDeBio Ltd.Refractory B-cell Acute Lymphoblastic Leukemia, Relapsed B-cell Acute Lymphoblastic Leukemia, Relapsed／Refractory B-cell Lymphoma
Start: 2017-03-02End: 2021-12-30Target: 24Updated: 2021-02-04
A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in Childhood R/R ALL and Lymphoma Subjects
NCT03265106
Shenzhen BinDeBio Ltd.Refractory B-cell Acute Lymphoblastic Leukemia, Childhood, Relapsed B-cell Acute Lymphoblastic Leukemia, Childhood, Relapsed/Refractory B-cell Lymphoma, Childhood
Start: 2016-11-01End: 2021-12-30Target: 20Updated: 2021-02-04